Rx Enforcement In 2025: Shift Away From Opioid Makers But Tougher Approach On Ad/Promo

 
• By Sue Sutter
  
2025 Pink Sheet Perspectives
DTC ads and compounded drugs could end up on opposite ends of the FDA enforcement pendulum. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Manufacturing